Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment

Publisher： Karger

E-ISSN： 1423-0194|92|1|44-49

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.92, Iss.1, 2010-09, pp. : 44-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coagulopathy in Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

Genetics of Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 6-10

Karger

Access to resources Recommend Favorite

Epidemiology of Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Metabolic Syndrome in Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 96-101

Karger

Access to resources Recommend Favorite

Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 116-119

Karger

Access to resources Recommend Favorite